4.6 Article

SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Virology

Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes

Jie Li et al.

Summary: COVID-19 presents with a variety of clinical features and outcomes, with an average age of 46.7 years, 51.8% of patients being male, 22.9% having severe disease, and a mortality rate of 5.6%. Severity of the disease is associated with factors such as age, gender, and comorbidities, which also increase the risk of mortality.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Cardiac & Cardiovascular Systems

Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019

Xiao-Yong Zhan et al.

Summary: This study retrospectively analyzed 602 COVID-19 patients from Hankou Hospital in Wuhan, China, showing that deceased patients had higher leukocyte and neutrophil counts, longer APTT and PT, and higher D-dimer and CRP levels. These parameters could serve as potential predictors for fatal outcomes in COVID-19 patients. The study also found that lymphopenia and aggressive inflammatory response might be major causes for fatal outcomes in elderly patients with cardiovascular-related comorbidities.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Review Cell Biology

The Impact of COVID-19 Disease on Platelets and Coagulation

Geoffrey D. Wool et al.

Summary: COVID-19 infection can lead to a proinflammatory state and abnormalities in the coagulation mechanism, with patients often experiencing thrombosis. Elevated levels of D-dimer are positively correlated with mortality, and patients typically exhibit mild thrombocytopenia.

PATHOBIOLOGY (2021)

Article Immunology

Complement activation and endothelial perturbation parallel COVID-19 severity and activity

Massimo Cugno et al.

Summary: The study found that complement activation is enhanced during the progression of COVID-19 and dampened during remission, indicating its role in the pathophysiology of the disease. The association between complement activation and the biomarkers of endothelial damage suggests that complement may contribute to tissue injury and could be the target of specific therapy.

JOURNAL OF AUTOIMMUNITY (2021)

Article Cardiac & Cardiovascular Systems

Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?

Franco Ruberto et al.

Summary: This study demonstrates that COVID-19 is associated with increased vWF-induced platelet agglutination but reduced platelet responsivity to aggregation stimuli.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Review Medicine, General & Internal

Clinical manifestations of COVID-19 in the general population: systematic review

Rodrigo da Rosa Mesquita et al.

Summary: This study systematically reviewed literature on the clinical manifestations of COVID-19 patients, identifying fever, cough, and dyspnea as the main symptoms. Other common symptoms included neurological symptoms, dermatological manifestations, and anorexia. Identifying all clinical manifestations is crucial for early diagnosis and prevention.

WIENER KLINISCHE WOCHENSCHRIFT (2021)

Article Virology

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity

Sijia He et al.

Summary: PSGL-1 is a cell surface glycoprotein that binds to selectins and has recently been found to possess antiviral activities. Research shows that expressing PSGL-1 in virus-producing cells can inhibit coronavirus replication and infection.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

Yu Zuo et al.

Summary: COVID-19 patients have elevated levels of tPA and PAI-1 in plasma, which are correlated with neutrophil counts and respiratory status. Particularly high levels of tPA are strongly associated with mortality and enhanced fibrinolysis, suggesting a subset of patients may have a favorable balance of factors for fibrinolysis. Further investigation into tPA as a biomarker is warranted.

SCIENTIFIC REPORTS (2021)

Review Cardiac & Cardiovascular Systems

Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis

Mouhand F. H. Mohamed et al.

Summary: Recent studies have shown a high prevalence of VTE in critically ill COVID-19 patients, with nearly 50% of patients detected with VTE through systematic screening. Initial analysis suggests that prophylactic anticoagulation may significantly increase the risk of VTE compared to therapeutic anticoagulation.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Multidisciplinary Sciences

ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida

Eduardo Oliveira et al.

Summary: Our study in the largest healthcare system in Florida described the clinical characteristics and outcomes of severe COVID-19 patients admitted to ICU. The study showed that survivors of severe COVID-19 had longer durations of mechanical ventilation, hospital stay, and ICU stay compared to non-survivors.

PLOS ONE (2021)

Article Microbiology

Clinical characteristics and outcomes of 1,331 patients with COVID-19: HM Spanish Cohort

Pablo Cardinal-Fernandez et al.

Summary: This study analyzed data of COVID-19 patients from 8 private hospitals in Spain, finding that age, male gender, leukocytes, platelets, oxygen saturation, chronic therapy with steroids, and treatment with hydroxychloroquine/azithromycin were associated with mortality. The mortality rate was higher in patients admitted to the intensive care unit, but no immunomodulatory interventions were associated with in-hospital mortality.

REVISTA ESPANOLA DE QUIMIOTERAPIA (2021)

Article Virology

Identification of the SHREK Family of Proteins as Broad-Spectrum Host Antiviral Factors

Deemah Dabbagh et al.

Summary: Research has identified a family of antiviral cellular proteins called the Surface-Hinged, Rigidly-Extended Killer (SHREK) that share structural similarities with PSGL-1. These proteins inhibit virus particle attachment to target cells, therefore blocking HIV-1 and other viral infections. These findings suggest that SHREK proteins may play a role in host innate immunity against enveloped viruses.

VIRUSES-BASEL (2021)

Review Immunology

Genetics Insight for COVID-19 Susceptibility and Severity: A Review

Ingrid Fricke-Galindo et al.

Summary: COVID-19 presents a broad spectrum of clinical manifestations, with genetic variants in HLA genes, cytokine genes, and ACE2/TMPRSS2 genes being potentially related to susceptibility and severity. Further research on the identified risk-genes and studies in different populations are needed.

FRONTIERS IN IMMUNOLOGY (2021)

Review Pediatrics

Biomarkers in COVID-19: An Up-To-Date Review

Madhusudan Samprathi et al.

Summary: Biomarkers play a crucial role in the COVID-19 pandemic, providing important information for clinical diagnosis and treatment. Different categories of biomarkers offer valuable insights, but there is still a lack of definitive answers on which biomarkers to evaluate when and in whom, and how best to utilize this information.

FRONTIERS IN PEDIATRICS (2021)

Review Medicine, General & Internal

Prevalence of Venous Thromboembolism in Critically Ill Patients With Coronavirus Disease 2019: A Meta-Analysis

Changgang Wu et al.

Summary: Critically ill patients with COVID-19 have a high prevalence of VTE, despite the use of present routine prophylactic anticoagulation.

FRONTIERS IN MEDICINE (2021)

Article Medicine, Research & Experimental

Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study

Emre Karsli et al.

Summary: This study demonstrates that sP-Selectin can serve as a valuable biomarker for diagnosing and predicting the need for intensive care treatment in COVID-19 infections.

LIFE SCIENCES (2021)

Review Surgery

A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019

Yandong Liu et al.

Summary: The occurrence of VTE, DVT, and pulmonary embolism is substantial among hospitalized patients with COVID-19, especially those with severe COVID-19. Patients with severe COVID-19 and VTE have significantly greater mortality compared with similar patients without VTE. An increased D-dimer level might indicate the occurrence of VTE in patients with COVID-19.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2021)

Article Infectious Diseases

Clinical progression of patients with COVID-19 in Shanghai, China

Jun Chen et al.

JOURNAL OF INFECTION (2020)

Article Medicine, General & Internal

Severe Covid-19

David A. Berlin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

Jacek Baj et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Pediatrics

Thromboinflammation in COVID-19 acute lung injury

William Beau Mitchell

PAEDIATRIC RESPIRATORY REVIEWS (2020)

Article Medicine, Research & Experimental

Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome

Marcelo Candido de Sa et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2018)

Article Clinical Neurology

Plasminogen Activator Inhibitor-1 and Thrombotic Cerebrovascular Diseases

Anna Tjarnlund-Wolf et al.

STROKE (2012)

Article Genetics & Heredity

PLINK: A tool set for whole-genome association and population-based linkage analyses

Shaun Purcell et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2007)

Article Hematology

Inter-relation of coagulation factors and D-dimer levels in healthy individuals

AV Vlieg et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)

Review Hematology

Factor IX and thrombosis

GDO Lowe

BRITISH JOURNAL OF HAEMATOLOGY (2001)

Review Genetics & Heredity

Genetic risk factors of venous thrombosis

RF Franco et al.

HUMAN GENETICS (2001)